Figure 4From: Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitorsCorrelation of plaque reduction and luciferase expression. CMV-infected HFF were treated with GCV, FOS, CHX, ART, dimer sulfone carbamate with the indicated drug concentrations. Luciferase expression was quantified in cell lysates 72 hpi. Plaque reduction was performed 10 days post infection. The correlation coefficient is provided for each experiment.Back to article page